Immatics (IMTX)

• Market cap: $1.27B
• 1 day: -2.58%
• 5 days: -6.44%
• 1 month: -6.71%
• 3 months: -8.61%
• 6 months: 42.53%
• Year to date: -9.57%
• 1 year: 77.3%
• 5 years: -11.1%
• 10 years: -1.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Employees: 423